Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Gynecol Oncol. 2016 Jun 4;142(2):217–224. doi: 10.1016/j.ygyno.2016.05.035

Table 1.

Preoperative and operative characteristics of patients who did and did not undergo a diverting ileostomy

Variable No DI (n=287) DI (n=44) p


n (%) n (%)

Age at surgery, yearsa (range) 61
(26–89)
63
(54–91)
.11

BMI, kg/m2a (range) 26.0
(16.3–50.9)
24.5
(19.1–42.7)
.13

Current smoker
  No 270 94 41 93 .74
  Yes 17 6 3 7

Former smoker
  No 180 63 27 61 .86
  Yes 107 37 17 39

Hypertension
  No 192 67 31 70 .64
  Yes 95 33 13 30

Diabetes
  No 275 96 38 86 .01
  Yes 12 4 6 14

Coronary artery disease
  No 284 99 41 93 .03
  Yes 3 1 3 7

AACCI group
  Low (score 0–1) 123 43 15 34 .45
  Intermediate (score 2–3) 134 47 25 57
  High (score ≥ 4) 30 10 4 9

Stage
  II 8 3 3 7 .16
  III 205 71 26 59
  IV 74 26 15 34

Histology
  High-grade serous 238 83 40 91 .37
  Low-grade serous 14 5 0 0
  Endometrioid 4 1 1 2
  Clear Cell 3 1 1 2
  Mixed/Other 28 10 2 5

Preoperative CA-125, U/mLa
(range)
480
(9–28503)
612
(55–8816)
.73

Preoperative hemoglobin, g/dLa
(range)
12.5
(8.6–14.8)
12.1
(8.4–14.9)
.07

Pre-operative albumin, g/dLa
(range)
4.1
(2.5–4.9)
4.2
(2.5–4.9)
.52

Ascites, La (range) 1.0
(0.0–13.0)
0.8
(0.0–12.0)
.45

Estimated blood loss, La (range) 1.0
(0.1–5.0)
1.2
(0.5–6.0)
.01

Total intraoperative IV fluids, La
(range)
7.7
(1.3–23.7)
9.9
(3.3–19.9)
.04

Operative time, h (range)a 6.2
(2.1–14.9)
8.1
(3.1–12.2)
<.01

Intraoperative complication
  No 243 85 32 73 .05
  Yes 44 15 12 27

Colon resection, non-rectosigmoid/
descending
  No 187 65 26 59 .43
  Yes 100 35 18 41

Rectosigmoid/descending colon
resection
  No 47 16 1 2 .01
  Yes 240 84 43 98

Length of rectosigmoid and
descending colon resection, cma
(range)
15.5
(0.0–53.2)
20.5
(0.0–54.8)
<.01

Total number of colon resections
  1 229 80 27 61 <.01
  2 or more 58 20 17 39

Total length of colon resection, cma
(range)
20.4
(1.5–108.5)
28.5
(6.0–88.0)
<.01

Cytoreductive status
  Optimal 263 92 39 89 .57
  Suboptimal 24 8 5 11

Residual disease
  0 cm 147 51 20 45 .70
  0.1–1 cm 116 40 19 43
  > 1 cm 24 8 5 11

DI, diverting ileostomy; AACCI, Age-Adjusted Charlson Comorbidity Index

a

Median